DNA N7 of purine bases (DNA N7)

The N7 position of purine bases, particularly guanine, is the most nucleophilic site within the DNA structure and serves as a major target for various chemotherapeutic agents (Hemminki, 1993). Alkylating agents and platinum-based drugs interact with this site to form covalent adducts that disrupt the double helix (Jamieson & Lippard, 1999). These modifications often result in intra-strand or inter-strand cross-links, which act as physical barriers to DNA replication and transcription (Fu et al., 2012). When the cell's repair machinery, such as nucleotide excision repair, cannot fix these lesions, the DNA damage response is activated, leading to apoptosis (StatPearls, 2023). This mechanism is particularly effective against rapidly proliferating cancer cells that have high rates of DNA synthesis. However, because the N7 position is present in all genomic DNA, these drugs lack high specificity, leading to significant side effects in healthy tissues (NIH, 2024). Monitoring biomarkers like MGMT methylation or BRCA status can help predict the efficacy of drugs targeting this site (PubMed, 2021).

Other names

N7-guanineN7-adenineN7-purine nucleophilic siteGuanine N7 positionAdenine N7 position

Covalent modification (alkylation or coordination) of the N7 nitrogen atom of purine bases, leading to DNA adducts and cross-links that inhibit DNA synthesis and induce apoptosis.